Abstract | OBJECTIVE: To explore whether the radioligand 2 beta-carboxymethoxy-3 beta-(4-[123I] iodophenyl) tropane ([123I] beta-CIT) and single-photon emission computed tomography (SPECT) can detect decreased striatal uptake in at-risk relatives of patients with Parkinson disease (PD). PATIENTS AND METHODS: Ten PD patients, 10 at-risk first-degree relatives of PD patients, and 10 controls underwent [123I] beta-CIT and SPECT brain imaging. Their striatal uptake ratios were compared. RESULTS: Age-adjusted specific to nonspecific striatal uptake ratios were lower in patients compared with controls and with relatives; however, ratios were similar in relatives and controls. Among relatives, ratios were consistently lower in subgroups postulated to be at higher risk for preclinical PD. CONCLUSION: Our findings provide preliminary support that [123I] beta-CIT and SPECT may detect decreased striatal uptake in relatives of PD patients postulated to be at higher risk for PD.
|
Authors | D M Maraganore, M K O'Connor, J H Bower, K M Kuntz, S K McDonnell, D J Schaid, W A Rocca |
Journal | Mayo Clinic proceedings
(Mayo Clin Proc)
Vol. 74
Issue 7
Pg. 681-5
(Jul 1999)
ISSN: 0025-6196 [Print] England |
PMID | 10405696
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Iodine Radioisotopes
- 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane
- Cocaine
|
Topics |
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Case-Control Studies
- Cocaine
(analogs & derivatives)
- Corpus Striatum
(diagnostic imaging)
- Female
- Humans
- Iodine Radioisotopes
- Male
- Middle Aged
- Parkinson Disease
(diagnostic imaging)
- Risk
- Tomography, Emission-Computed
(methods)
- Tomography, Emission-Computed, Single-Photon
(methods)
|